Reproductive Medicine International is an open access and peer-reviewed journal committed to promote the best standards of scientific discoveries and knowledge in the field of sexual medicine and reproductive disorders and management. Reproductive Medicine International acts a best source of information for the researchers, reproductive health experts and practitioners.
Reproductive Medicine International is a newly launched journal which elaborates author benefits along with reliable copy rights policy. All articles published in the journal will be subjected to peer review process. It encourages authors to publish their experimental and theoretical results in as much detailed as possible.
The Journal covers various topics of erectile dysfunction, infertility, menopause, sexual health and reproductive technologies, reproductive health, male and female sexual function, sexual disorders, STDs, genito-urinary disorders, reproductive system, sexual behavior, obstetrics, reproductive endocrinology, urinary tract infections, sexually transmitted diseases, male infertility, sexual pains, etc.
Articles Search by Keyword | Journal title | Author name | DOI
Open Access DOI:10.23937/rmi-2017/1710006
Ellen Casey, Travis Anderson, Laurie Wideman, Frances F Shofer and Sandra J Shultz
Article Type: Original Research | First Published: August 25, 2018
Sex disparity in anterior cruciate ligament injury is multifactorial. Sex hormones, such as relaxin, may play a role in the increased risk of injury in female athletes. In order to fully investigate this relationship, optimal strategies for capturing serum relaxin concentration across the menstrual cycle must be determined. The aim of this study was to describe the variability in the timing and magnitude of relaxin concentration changes across th...
Open Access DOI:10.23937/rmi-2017/1710005
M Angeles Martos, Virginia Engels, Beatriz Bueno, Angel Salcedo, Tirso Perez-Medina and Luis San-Frutos
Article Type: Research Article | First Published: July 26, 2018
Models for predicting the success of labor induction can be used to improve clinical decision. The aim of this study was to create nomogram based on clinical, sonographic and biochemical parameters, to provide an individualized prediction of success of induction....
Open Access DOI:10.23937/rmi-2017/1710004
Baquedano L, Sanchez Borrego R, Abad P, Jurado AR, Manubens M and Mendoza N
Article Type: Review Article | First Published: July 13, 2018
Menopause is not a disease, therefore it is not always necessary to treat women in the transition and in menopause. However, hormonal changes can be associated with symptoms, the most common are hot flashes and night sweats. Others like dyspareunia, vaginal dryness, mood swings and sexual disfunction can frequently appear. In addition, there is an increase in bone resorption on ocassions leading to osteopenia and osteoporosis. Women who are severely symptomatic, 25-30% more or less of all menopa...
Open Access DOI:10.23937/rmi-2017/1710003
Mohamed Nabih EL-Gharib
Article Type: Short Communication | First Published: June 25, 2018
Homocysteine (Hcy) is an essential amino acid required for the growth of cells and tissues. Homocysteine (Hcy) is an intermediate product formed by the breakdown of methionine the aid of certain B-vitamins. Homocysteine remethylation to methionine is dependant on both folate and cobalamin (Figure 1) and may undergo transsulfuration to cysteine and cystathionine....
Open Access DOI:10.23937/rmi-2017/1710002
Monica S Chung, Laurice Bou Nemer and Bruce R Carr
Article Type: Mini Review | First Published: June 06, 2018
Luteal Phase Deficiency (LPD), also known as luteal phase defect, is a concept that was defined by Georgeanna Seegar Jones in 1949 as reduced progesterone production by the Corpus Luteum (CL). LPD results from low endogenous progesterone production and the resultant insufficiency to maintain a secretory endometrium to allow embryo implantation and growth....
Open Access DOI:10.23937/rmi-2017/1710001
Shahar Kol and Ofer Fainaru
Article Type: Case Report | First Published: May 30, 2018
The use of short acting GnRH agonist to trigger final oocyte maturation in IVF is a common practice. Its primary advantage is prevention of significant ovarian hyperstimulation syndrome. The effect of a long acting GnRH agonist preparation in that setting is not known. In the current case report, a depot preparation was given accidentally, resulting in prolonged and robust luteal phase activity, with luteolysis achieved only 14 days after administration....
ClinMed International Library
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Contact our editorial office